Latest Prescription Drugs news
Subcutaneous mAb May Benefit High-Risk Outpatients With COVID-19
posted April 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
First Generic of Symbicort Receives FDA Approval
posted April 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
DMARD Prescribing Low for Older Adults With Rheumatoid Arthritis
posted April 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Intra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis
posted April 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Research Challenges Fusion for Lumbar Degenerative Spondylolisthesis 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
